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Abstract
Genetic research on fibrosis outset and its progression in chronic hepatitis (CH) by hepatitis C virus (HCV) are lim-
ited. The lack of cytogenetic data led us to investigate the presence of micronuclei (MNi), as a sign of genomic dam-
age. Hepatocytes of hepatic parenchyma from 62 cases diagnosed with CH associated with HCV and displaying
different degrees of fibrosis (F1-F4) were analyzed. These data were compared to 15 cases without fibrosis (F0).
Twelve healthy liver parenchyma samples were included as control. All samples were obtained from paraf-
fin-embedded archival material. Micronucleated hepatocytes (MN-Heps) were analyzed through Feulgen/Fast-
green staining. Results showed that the rates of MN-Heps in the F4 group were statistically significant (p < 0.05) and
higher than those in the control group. Like results were also obtained on comparing F4 with F0, F1, F2 and F3 cases.
Conversely, differences were not significant (p > 0.05) on comparing F0, F1, F2, F3, one against the other, as well as
individual versus control. Although chromosomal losses in CH were detected, it was shown that liver parenchyma
with fibrosis in the initial stages (F1-F3) cannot be considered cytogenetically abnormal.
Key words: micronuclei, hepatocytes, chronic hepatitis C, fibrosis progression, HCV-patients.
Received: July 21, 2009; Accepted: February 23, 2010.
Introduction
Chronic infection by hepatitis C virus (HCV) is both
slow and insidious. 80% of HCV individuals are prone to
infection worldwide. From these, over 30% develop
chronic liver diseases, including cirrhosis, a major risk for
developing hepatocellular carcinoma (HCC) (Thomson
and Finch, 2005). This possibility is about 17 times higher
in HCV infected patients than in uninfected (Donato et al.
2001). However, the evolution of chronic hepatitis (CH)
varies in HCV infected patients, due, not only to the time of
infection, but also to the extent of fibrosis generated| by
hepatic parenchyma during the necro-inflammatory pro-
cess (Kiyozawa, 2002; But et al., 2008). The elimination of
hepatocytes in CH/HCV during the necro-inflammatory
process is followed by accelerated cell division, thereby
leading to various grades of fibrosis (F1-F4). In spite of this
type of cell proliferation induced by chronic lesion, the
liver may still be considered functionally competent (Cal-
lea et al., 1991). The intense hepatocyte turnover may make
all cells susceptible to genetic variation, this including
cytogenetic instability, thus creating propitious conditions
for the development of the various stages of hepatocarci-
nogenesis (Kitamura et al., 1998).
There are no data available on chromosomal instabil-
ity from the onset of the fibrosis progression caused by vi-
rus infection in human beings. However, cytogenetic
changes in micronucleated hepatocytes (MN-Heps)
through chromatin loss were found in CH/HCV-F4 in re-
generative cirrhotic nodules without atypia (Almeida et al.,
2004; Guido et al., 2008; Kim et al., 2009). Micronuclei
may originate either from acentric fragments, resulting
from chromosomal/chromatid breaks, or from whole chro-
mosomes, unable to migrate with the remainder chromo-
somes in anaphase, and being included in one or more
secondary nuclei in daughter cells. Thus, MN assays can be
used to evaluate clastogenic and aneugenic effects (Heddle
et al., 1991; Fenech, 2000). The hypothesis was that micro-
nuclei, as the result of chromosome breakage/anaphase lag-
ging, might occur in CH/HCV at the start of the fibrotic
process, and increasing in cirrhosis and in HCC. To check
this hypothesis, MN-Hep frequencies inside CH/HCV liver
parenchyma with (F1-F4) or without fibrosis (F0) and with
normal parenchyma (NP), were examined.
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Material and Methods
Liver tissue samples from 89 individuals, both male
and female (age 18-60), were analyzed. Study material con-
sisted of hepatocytes in 77 samples from CH|HCV patients
without fibrosis (F0), and parenchyma with fibrosis in the
initial (F1, F2, F3) and final (F4) stages, as well as samples
from twelve healthy donors - NP (control group). All the
samples were retrospective from 2002 to 2007, and collected
from the Laboratório de Anatomia Patológica Diagnóstika,
São Paulo, Brazil. According to clinical references, the pa-
tients had not been previously exposed to any kind of etio-
logical agent, including those known as mutagenic.
Tissue samples
CH/HCV samples were separated into the following
groups: F0 (15); F1 (14); F2 (16); F3 (15); F4 (17), plus 12
control individuals. Retrospective studies were performed
on liver samples fixed in 10% formalin and embedded in
paraffin blocks. For light microscopy, each sample in par-
affin blocks was cut into 3-5 m-thick sections and stained
with hematoxylin-eosin in order to choose the areas to be
studied. The fibrosis-stage for investigation in each case
was determined by the histological characteristics imputed
by both the METAVIR system (The French METAVIR
Cooperative Study Group, 1994) and International Wor-
king Party (1995). These are: F0- without fibrosis; F1- mild
fibrosis; F2- moderate fibrosis; F3- severe fibrosis and F4-
cirrhosis in regenerative nodules (RNs) without atypia. The
normal hepatic parenchyma was chosen at random. After
establishing these areas the samples were prepared for
MN-Heps analysis.
Detection of micronuclei
Slides were stained by the Feulgen reaction and
counterstained with fast-green, as described by Almeida et
al. (2004). Each slide was code-labeled, so as to avoid ob-
server bias, and examined at 1250x magnification with a
standard optical microscope (Olympus BX-50). The num-
ber of hepatocytes scored was usually 2000 per sample. The
same criteria described by Almeida et al. (2004) were used
for evaluating MN-Heps. This cytogenetic evaluation was
carried out with 178,000 mononucleated hepatocytes from
the following chronic hepatitis parenchyma (CHP) groups:
30,000 (F0); 28,000 (F1); 32,000 (F2); 30,000 (F3) and
34,000 (F4), besides 24,000 with normal parenchyma (NP).
The results were all expressed according to the number of
MN-Heps per 1000 hepatocytes (‰).
Statistical analysis
Since data were not normally distributed, differences
among groups were checked through nonparametric analy-
sis of variance (Kruskall-Wallis test), followed by a multi-
ple comparisons test in order to locate those comparisons
responsible for significance of the test. Commercial (SPSS
Inc., Chicago, IL, USA) and public domain (Online R
Development Team, 2009) softwares were used for all
mentioned statistical analyses.
Results
The distribution of micronuclei (MNi) per
hepatocyte in the F0, F1, F2, F3 and F4 groups, irrespec-
tive of parenchymal area, and even in the NP (control
group) indicated only one MN in most cells (95.6%), as
shown in Figure 1A, B, C. In the F0 group, in about 22%
of the cases, incidence was one or two MNi per cell (Fig-
ure 1D), the same occurring in the F3 and F4 groups, al-
though, in the control group, in 30% of the cells, this was
one to three MNi. In most NP cells, incidence was one MN
per cell, although 6 hepatocytes with two MNi each were
also found. The MN-Heps evaluated in the parenchyma of
each group were of different sizes. In F0-F3 groups size
mostly varied from medium (1/10 diameter of the main
nucleus) to large (1/5) (Figure 1C, D). In F4, most MNi
small-sized (1/15), even when there were two (Figure 1A,
B). MN-Hep frequencies were obtained from CHP in dif-
ferent stages of fibrosis (F1, F2, F3, F4), as well as paren-
chyma without fibrosis (F0) and in NP. Median values
(range) were distributed, as follows: F0: 6 (1-14), N = 15;
F1: 5 (2-15), N = 14; F2: 7 (1-11), N = 16; F3: 6 (1-10),
N = 15; F4: 11 (4-33), N = 17 and control: 5.5 (1-9),
N = 12, p = 0.001 (Kruskall-Wallis test); (Figure 2). Table
1 shows p values calculated from multiple comparisons of
MN-Heps data on NP, as well as the progression of fibro-
Almeida et al. 419
Figure 1 - Photomicrographs of micronucleated hepatocytes detected with
Feulgen-fast-green staining in interphasic nuclei from chronic hepati-
tis-HCV parenchyma and normal liver tissues. Irrespective of analyzed
area and even in normal parenchyma, most cells presented only one
micronucleus (Panels A, C, D). Panel B: a micronucleated hepatocyte with
two micronuclei. Variation in size: hepatocytes with (A) small micro-
nucleus, (B) two small micronuclei, (C) medium micronucleus, (D) large
micronucleus. Arrows indicate micronuclei.
sis (F0 to F4). Only the F4 group showed statistically sig-
nificant differences (p < 0.05).
Discussion
To the best of our knowledge, this is the first study on
chromatin loss, evaluated by MN formation, in liver sam-
ples from patients with CH/HCV during the fibrosis pro-
gression. A retrospective study of serial sections enabled us
to evaluate CHP samples, which, through being particu-
larly homogeneous, assured the detection of MN-Hep fre-
quency. The results are consistent with the hypothesis that
cytogenetic instability is already present in the initial stages
of fibrosis, although the alterations in CHP (F1, F2, F3) dif-
fered neither mutually nor significantly, not even in those
without fibrosis (F0) or in NP. On the contrary, the rate of
MN-Heps in cirrhotic parenchyma (F4) was higher and dif-
ferent (p < 0.05) from F0, F1, F2 and F3, even though
93%-100% of the F1, F2, F3, F4 analyzed cases were with
A1 and A2 inflammatory activity. Due to cirrhosis com-
plexity, it is suggested that the long period of inflammation,
inherent in HCV, may have caused an increase in prolifera-
tion, this contributing to the formation of MNi. Most of the
MNi found in all cases of CH/HCV were medium to large
sized, as already described in our previous work on HCV
cirrhosis (Almeida et al. 2004). Oxidative and nitrosactive
stress in CH/HCV (Choi and Ou, 2006; Seronello et al.,
2007) may cause both genotoxicity and, mutagenicity in
hepatocytes. This phenomenon may create chromosomal
instability (MN formation) in the diverse stages of fibrotic
development in various ways (clastogenicity - chromatid
breaks and/or aneugenicity - chromosome loss). The for-
mation of MN by clastogenicity mechanisms has already
been shown in genotoxic-induced hepatomas (Canonero et
al., 1997; Sanyal et al., 1997), as well as in the evaluation of
aneugenic substances (Fimognari et al., 1997). The loss of
spindle assembly checkpoints often occurs with a high fre-
quency in HCC with chromosomal instability (Saeki et al.,
2002). The formation of MNi originating from several
chromosomes was also obtained in human hepatoma
HepG2 cells transfected with hepatitis B virus (HBV)-X
genes, thereby providing evidence of alterations in geno-
mic integrity (Livezey et al., 2002). Studies of liver-cell
lines showed that overexpression in hepatitis C virus NS5A
protein is also directly involved in the formation of chro-
mosome instability by mitotic cycle disregulation (Baek et
al., 2006). Thus, it is possible that the hypercarcinogenic
state, due to chronic HCV infection (Hino et al., 2002),
might be associated with several genetic and epigenetic
events, thereby explaining the presence of different-sized
MN. Nevertheless, there was no relationship between MNi
detected during fibrosis progression and changes in CHP
morphological characteristics. We consider that the offset
and increase in premature cytogenetic instability may play
an important role in the innumerable lesions arising during
CH/HCV evolution towards F4 (cirrhosis). A further con-
clusion of this work concerns the apparent cytogenetic nor-
mality of fibrotic parenchyma (F1-F3) in spite of chromo-
some loss evidenced by MN formation in liver hepatocytes
during the development of CH/HCV.
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